A Food and Drug Administration advisory committee voted Wednesday to recommend that three psychiatric drugs be approved for use in children.
The panel made up of outside experts said that Seroquel, Geodon and Zyprexa appear safe and effective to treat bipolar disorder and schizophrenia in children as young as 10. The medications are already approved for use in adults and may be prescribed to children, though they are not specifically approved for such use.
The vote on Wednesday amounts to a recommendation only. The FDA typically follows the advice of its advisory panels, but does not have to.
Approval would allow the drugs’ makers to market the medications to this new demographic.
While the advisory panel voted overwhelmingly in favor of using the three drugs known as atypical antipsychotics in children, there are significant concerns about side effects like sedation and weight gain. Plus, little is know about the long-term impact the drugs may have.
More in Health & Behavior »
More in Autism »
Copyright © 2009 Disability Scoop, LLC. All Rights Reserved.
Post a Comment
Comments are moderated and will not appear until they are approved. All comments must be in compliance with the DisabilityScoop.com Terms and Conditions. Please stay on-topic, keep your comments brief and refrain from inserting links or using abusive language.
You must be logged in to post a comment. Click here to login or register.
Eli Lilly Zyprexa can cause diabetes
I took Zyprexa a powerful Lilly schizophrenic drug for 4 years it was prescribed to me off-label for post traumatic stress disorder was ineffective costly and gave me diabetes.
This is a powerful drug that can damage a young person physiologically for life.
Please take with caution and learn as much as you can about side effects.
Eli Lilly’s #1 cash cow Zyprexa drug sale $38 billion dollars so far,has a ten times greater risk of causing type 2 diabetes over the non-user of Zyprexa.
So,here we have a conflict of interest that this same company also is a big profiteer of diabetes treatment.
Daniel Haszard